|Dr. Ken Lu|
Dr. Ken Lu has been our independent director since August 2006. Dr. Lu is a managing director of Seres Asset Management Limited, an investment management company focusing on the Asian equity markets. Prior to Seres, Dr. Lu founded and managed APAC Capital Advisors Limited, a Greater China investment specialist, from 2004 to early 2010. Dr. Lu’s extensive capital market experience also includes research analyst roles at a number of leading investment banks, including JP Morgan and Credit Suisse (formerly Credit Suisse First Boston, or CSFB). He served as the Head of China Research at CSFB from October 2001 to May 2004, managing a team of over 10 research analysts and directing CSFB’s overall China research products. Mr. Lu also serves on the boards and audit committees of Asia Info Holdings, Inc., a company listed on the NASDAQ, Enerchina Holdings Ltd, a company listed on the Hong Kong Stock Exchange, and China Cord Blood Corporation, a company listed on the main board of New York Stock Exchange. Dr. Lu holds a Bachelor of Science degree from the Beijing University in 1985, a Master of Science from the Brigham Young University in 1988, and a Ph. D. degree in finance from the University of California, Los Angeles in 1995.